Table 1.
Means (and standard deviation) of baseline characteristics of study participants by treatment group
| Incentive Voucher with Coaching | Medication Coaching Alone | |||
|---|---|---|---|---|
| Number of participants | 34 | 32 | ||
| Gender (% female) | 35 | 47 | ||
| Age (years) | 44.0 | (7.8) | 42.6 | (7.8) |
| Ethnicity | ||||
| Caucasian (%) | 44 | 28 | ||
| African-American (%) | 26 | 37 | ||
| Latino (%) | 15 | 9 | ||
| Other (%) | 17 | 26 | ||
| Married (%) | 24 | 3 | ||
| Employed (full or part-time, %) | 9 | 0 | ||
| Yearly income < $10,000 (%) | 85 | 81 | ||
| Opiates (% positive urine screen) | 35 | 41 | ||
| Cocaine (% positive urine screen) | 53 | 50 | ||
| Addiction Severity Index drug composite | 0.21 | (0.1) | 0.21 | (0.1) |
| Addiction Severity index alcohol use composite | 0.09 | (0.2) | 0.04 | (0.1) |
| SF-36 physical health summary | 24.6 | (1.2) | 24.3 | (1.5) |
| Plasma HIV-1 RNA (copies) [median] | 8,885 | [57] | 21,063 | [0] |
| Plasma HIV-1 RNA < 75 copies/ml detection limit (%) | 50.0 | 50.0 | ||
| CD4+ (Cells/UL) | 302 | (198) | 299 | (330) |
| Adherence by electronic monitor during baseline period (%) | 50.1 | (17.2) | 51.9 | (20.0) |
| Adherence by pill count during baseline period (%) | 70.5 | (20.9) | 79.1 | (18.8) |
| Adherence by self-report during baseline period (%) | 75.0 | (22.4) | 75.9 | (25.0) |